Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Approaches to Measuring the Activity of Major Lipolytic and Lipogenic Enzymes In Vitro and Ex Vivo

M. Wilhelm, L. Rossmeislová, M. Šiklová

. 2022 ; 23 (19) : . [pub] 20220921

Language English Country Switzerland

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc22033284

Since the 1950s, one of the goals of adipose tissue research has been to determine lipolytic and lipogenic activity as the primary metabolic pathways affecting adipocyte health and size and thus representing potential therapeutic targets for the treatment of obesity and associated diseases. Nowadays, there is a relatively large number of methods to measure the activity of these pathways and involved enzymes, but their applicability to different biological samples is variable. Here, we review the characteristics of mean lipogenic and lipolytic enzymes, their inhibitors, and available methodologies for assessing their activity, and comment on the advantages and disadvantages of these methodologies and their applicability in vivo, ex vivo, and in vitro, i.e., in cells, organs and their respective extracts, with the emphasis on adipocytes and adipose tissue.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22033284
003      
CZ-PrNML
005      
20230131150736.0
007      
ta
008      
230120s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms231911093 $2 doi
035    __
$a (PubMed)36232405
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Wilhelm, Marek $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic $1 https://orcid.org/0000000156809851
245    10
$a Approaches to Measuring the Activity of Major Lipolytic and Lipogenic Enzymes In Vitro and Ex Vivo / $c M. Wilhelm, L. Rossmeislová, M. Šiklová
520    9_
$a Since the 1950s, one of the goals of adipose tissue research has been to determine lipolytic and lipogenic activity as the primary metabolic pathways affecting adipocyte health and size and thus representing potential therapeutic targets for the treatment of obesity and associated diseases. Nowadays, there is a relatively large number of methods to measure the activity of these pathways and involved enzymes, but their applicability to different biological samples is variable. Here, we review the characteristics of mean lipogenic and lipolytic enzymes, their inhibitors, and available methodologies for assessing their activity, and comment on the advantages and disadvantages of these methodologies and their applicability in vivo, ex vivo, and in vitro, i.e., in cells, organs and their respective extracts, with the emphasis on adipocytes and adipose tissue.
650    _2
$a tukové buňky $x metabolismus $7 D017667
650    _2
$a tuková tkáň $x metabolismus $7 D000273
650    _2
$a lidé $7 D006801
650    12
$a lipogeneze $7 D050155
650    12
$a lipolýza $7 D008066
650    _2
$a obezita $x metabolismus $7 D009765
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Rossmeislová, Lenka $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic $u Franco-Czech Laboratory for Clinical Research of Obesity, Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic
700    1_
$a Šiklová, Michaela $u Department of Pathophysiology, Center for Research on Nutrition, Metabolism and Diabetes, Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic $u Franco-Czech Laboratory for Clinical Research of Obesity, Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic $1 https://orcid.org/0000000304891069
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 23, č. 19 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36232405 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131150733 $b ABA008
999    __
$a ok $b bmc $g 1891833 $s 1184619
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 23 $c 19 $e 20220921 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
LZP    __
$a Pubmed-20230120

Find record

Citation metrics

Archiving options